Molecular insight of dyskeratosis congenita: Defects in telomere length homeostasis
- PMID: 35097237
- PMCID: PMC8791241
Molecular insight of dyskeratosis congenita: Defects in telomere length homeostasis
Abstract
Background: Dyskeratosis congenita (DC) is a rare disease and is a heterogenous disorder, with its inheritance patterns as autosomal dominant, autosomal recessive, and X-linked recessive. This disorder occurs due to faulty maintenance of telomeres in stem cells. This congenital condition is diagnosed with three symptoms: oral leukoplakia, nail dystrophy, and abnormal skin pigmentation. However, because it has a wide range of symptoms, it may have phenotypes similar to other diseases. For this reason, it is necessary to use methods of measuring the Telomere Length (TL) and determining the shortness of the telomere in these patients so that it can be distinguished from other diseases. Today, the Next Generation Sequencing technique accurately detects mutations in the target genes.
Aim: This work aims to review and summarize how each of the DC genes is involved in TL, and how to diagnose and differentiate the disease using clinical signs and methods to measure TL. It also offers treatments for DC patients, such as Hematopoietic Stem Cell Transplantation and Androgen therapy.
Relevance for patients: In DC patients, the genes involved in telomere homeostasis are mutated. Because these patients may have an overlapping phenotype with other diseases, it is best to perform whole-exome sequencing after genetics counseling to find the relevant mutation. As DC is a multi-systemic disease, we need to monitor patients frequently through annual lung function tests, ultrasounds, gynecological examinations, and skin examinations.
Keywords: diagnosis; dyskeratosis congenita; shelterin; telomerase; treatment.
Copyright: © Whioce Publishing Pte. Ltd.
Conflict of interest statement
The authors declare no conflict of interests.
Figures



Similar articles
-
The diagnosis and treatment of dyskeratosis congenita: a review.J Blood Med. 2014 Aug 21;5:157-67. doi: 10.2147/JBM.S47437. eCollection 2014. J Blood Med. 2014. PMID: 25170286 Free PMC article. Review.
-
Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.Cell Cycle. 2005 Apr;4(4):585-9. Epub 2005 Apr 3. Cell Cycle. 2005. PMID: 15753647
-
Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.BMC Med Genet. 2018 May 25;19(1):85. doi: 10.1186/s12881-018-0584-y. BMC Med Genet. 2018. PMID: 29801475 Free PMC article.
-
[Research progress of dyskeratosis congenita].Zhonghua Kou Qiang Yi Xue Za Zhi. 2019 Feb 9;54(2):130-134. doi: 10.3760/cma.j.issn.1002-0098.2019.02.010. Zhonghua Kou Qiang Yi Xue Za Zhi. 2019. PMID: 30695916 Review. Chinese.
-
Recent progress in dyskeratosis congenita.Int J Hematol. 2010 Oct;92(3):419-24. doi: 10.1007/s12185-010-0695-5. Epub 2010 Oct 1. Int J Hematol. 2010. PMID: 20882440 Review.
Cited by
-
Telomere biology: from disorders to hematological diseases.Front Oncol. 2023 May 19;13:1167848. doi: 10.3389/fonc.2023.1167848. eCollection 2023. Front Oncol. 2023. PMID: 37274248 Free PMC article. Review.
-
The importance of pseudouridylation: human disorders related to the fifth nucleoside.Biol Futur. 2023 Jun;74(1-2):3-15. doi: 10.1007/s42977-023-00158-3. Epub 2023 Mar 31. Biol Futur. 2023. PMID: 37000312 Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials